Anti-FLI1 antibody [EPR4646]
- RabMAb
- Recombinant
- Advanced Validation
- What is this?
5
(1 Review)
|
(46 Publications)
Anti-FLI1 antibody [EPR4646] (ab133485) is a rabbit monoclonal antibody detecting FLI1 in Western Blot, IHC-P. Suitable for Human, Mouse.
- Biophysical QC for unrivalled batch-batch consistency
- Over 30 publications
View Alternative Names
Friend leukemia integration 1 transcription factor, Proto-oncogene Fli-1, Transcription factor ERGB, FLI1
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FLI1 antibody [EPR4646] (AB133485)
Immunohistochemical analysis of formalin fixed paraffin embedded human lung labelling FLI1 with ab133485 at a concentration of 0.01 µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with a OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was performed with DISCOVERY cell conditioning solution (CC1) 100°C, pH 8.5 for 32mins.
ab133485 Anti-FLI1 antibody [EPR4646] was incubated for 16mins at 37°C. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
Customers are encouraged to optimise antigen retrieval conditions, antibody concentration, incubation times and temperature for best results in their own IHC assay workflow (automated and manual).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FLI1 antibody [EPR4646] (AB133485)
Immunohistochemical analysis of paraffin-embedded Human Ewing sarcoma tissue labelled with unpurified ab133485 at 1/250 dilution.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FLI1 antibody [EPR4646] (AB133485)
Immunohistochemical staining of paraffin embedded human lung with unpurified ab133485 at a working dilution of 1 in 140. The secondary antibody used is a HRP polymer for rabbit IgG. The sample is counter-stained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer, pH 9.0.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-FLI1 antibody [EPR4646] (AB133485)
Immunohistochemical staining of paraffin embedded human lung with purified ab133485 at a working dilution of 1 in 700. The secondary antibody used is a HRP polymer for rabbit IgG. The sample is counter-stained with hematoxylin. Antigen retrieval was perfomed using Tris-EDTA buffer, pH 9.0.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-FLI1 antibody [EPR4646] (AB133485)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 105 A-673 (human muscle Ewings sarcoma cell line) cells and 5 µg of ab133485 [EPR4646]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-FLI1 antibody [EPR4646] (AB133485)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 105 A-673 (human muscle Ewings sarcoma cell line) cells and 5 µg of ab133485 [EPR4646]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-FLI1 antibody [EPR4646] (AB133485)
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 105 A-673 (human muscle Ewings sarcoma cell line) cells and 5 µg of ab133485 [EPR4646]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- WB
Lab
Western blot - Anti-FLI1 antibody [EPR4646] (AB133485)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-FLI1 antibody [EPR4646] (ab133485) at 1/1000 dilution
All lanes:
Jurkat cell lysate at 10 µg
Secondary
All lanes:
HRP goat anti-rabbit at 1/1000 dilution
Predicted band size: 51 kDa
Observed band size: 51 kDa
false
- WB
Unknown
Western blot - Anti-FLI1 antibody [EPR4646] (AB133485)
Blocking buffer : 5% NFDM/TBST
Dilution buffer : 5% NFDM/TBST
All lanes:
Western blot - Anti-FLI1 antibody [EPR4646] (ab133485) at 1/200 dilution
All lanes:
Jurkat cell lysate at 10 µg
Secondary
All lanes:
HRP goat anti-rabbit (H+L) at 1/1000 dilution
Predicted band size: 51 kDa
Observed band size: 51 kDa
false
- WB
Unknown
Western blot - Anti-FLI1 antibody [EPR4646] (AB133485)
All lanes:
Western blot - Anti-FLI1 antibody [EPR4646] (ab133485) at 1/1000 dilution
Lane 1:
U937 cell lysate at 10 µg
Lane 2:
Jurkat cell lysate at 10 µg
Lane 3:
Raw264.7 cell lysate at 10 µg
Lane 4:
HL-60 cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 51 kDa
false
- WB
Unknown
Western blot - Anti-FLI1 antibody [EPR4646] (AB133485)
All lanes:
Western blot - Anti-FLI1 antibody [EPR4646] (ab133485) at 1/1000 dilution
Lane 1:
FLI1 recombinant protein at 0.01 µg
Lane 2:
ERGrecombinant protein at 0.01 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 51 kDa
false
Related conjugates and formulations (1)
-
Anti-FLI1 antibody [EPR4646] - BSA and Azide free
Reactivity data
Product details
Product Specifications
Anti-FLI1 antibody [EPR4646] (ab133485) is a rabbit recombinant monoclonal antibody and is validated for use in ChIC/CUT&RUN-seq, IHC-P, WB in human and mouse samples.
Anti-FLI1 antibody [EPR4646] (ab133485) specifically detects FLI1 (UniProt ID: Q01543; Molecular weight: 51kDa) and is sold in 100 µL and 1 mL selling sizes.
Quality and Validation
Abcam's high quality manufacturing and validation processes ensure Anti-FLI1 antibody [EPR4646] (ab133485) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
Anti-FLI1 antibody [EPR4646] (ab133485) has been cited over 30 times in peer reviewed journals and is trusted by the scientific community.
Related Products
Conjugation-ready, carrier free format available for antibody clone EPR4646 - ab215987.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The FLI1 protein influences cell proliferation differentiation and apoptosis. It also plays a role in the regulation of genes involved in the immune response. FLI1 forms complexes with other proteins to exert its function therefore impacting gene expression in cellular contexts. Its participation in these processes indicates its regulatory impact on normal cellular development and function.
Pathways
FLI1 interacts with signaling networks that govern the hematopoietic lineage and endothelial cell function. It participates in the MAPK/ERK pathway influencing cell cycle and growth signaling. Through these pathways FLI1 has functional interactions with proteins such as GATA1 and RUNX1 establishing its importance in vascular development and hematopoiesis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (46)
Recent publications for all applications. Explore the full list and refine your search
Cancer research communications 5:1034-1048 PubMed40478628
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of inflammation research 18:4213-4231 PubMed40129872
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 44:115381 PubMed40080499
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports methods 5:100966 PubMed39922188
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:1267 PubMed39894896
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed39769192
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 45:181-200 PubMed39651397
2024
Applications
Unspecified application
Species
Unspecified reactive species
Development (Cambridge, England) 151: PubMed39612288
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature cardiovascular research 3:1158-1176 PubMed39271818
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed39201282
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com